Showing 1 - 8 results of 8 for search 'Guillermo Martinez-de-Tejada', query time: 0.03s Refine Results
  1. 1
    Antimicrobial Peptides in the Battle against Orthopedic Implant-Related Infections: A Review

    Antimicrobial Peptides in the Battle against Orthopedic Implant-Related Infections: A Review by Bruna Costa, Guillermo Martínez-de-Tejada, Paula A. C. Gomes, M. Cristina L. Martins, Fabíola Costa

    Published 2021-11-01
    Get full text
    Article
  2. 2
    A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis

    A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis by Klaus Brandenburg, Raquel Ferrer-Espada, Guillermo Martinez-de-Tejada, Christian Nehls, Satoshi Fukuoka, Karl Mauss, Günther Weindl, Patrick Garidel

    Published 2023-10-01
    Get full text
    Article
  3. 3
    Supramolecular assembly of micellar aggregates is the basis of low endotoxin recovery (LER) in a drug formulation that can be resolved by a whole blood assay

    Supramolecular assembly of micellar aggregates is the basis of low endotoxin recovery (LER) in a drug formulation that can be resolved by a whole blood assay by Andra B. Schromm, Wilmar Correa, Nicolas Gisch, Frank Steiniger, Walter Richter, Guillermo Martinez-de-Tejada, Klaus Brandenburg, Friedrich von Wintzingerode

    Published 2024-04-01
    Get full text
    Article
  4. 4
    Activity of Anti-Microbial Peptides (AMPs) against <i>Leishmania</i> and Other Parasites: An Overview

    Activity of Anti-Microbial Peptides (AMPs) against <i>Leishmania</i> and Other Parasites: An Overview by Rima El-Dirany, Hawraa Shahrour, Zeinab Dirany, Fadi Abdel-Sater, Gustavo Gonzalez-Gaitano, Klaus Brandenburg, Guillermo Martinez de Tejada, Paul A. Nguewa

    Published 2021-07-01
    Get full text
    Article
  5. 5
    Inhibition of Lipopolysaccharide- and Lipoprotein-Induced Inflammation by Antitoxin Peptide Pep19-2.5

    Inhibition of Lipopolysaccharide- and Lipoprotein-Induced Inflammation by Antitoxin Peptide Pep19-2.5 by Lena Heinbockel, Günther Weindl, Guillermo Martinez-de-Tejada, Wilmar Correa, Susana Sanchez-Gomez, Sergio Bárcena-Varela, Torsten Goldmann, Patrick Garidel, Thomas Gutsmann, Klaus Brandenburg

    Published 2018-07-01
    Get full text
    Article
  6. 6
    Anti-Infective and Anti-Inflammatory Mode of Action of Peptide 19-2.5

    Anti-Infective and Anti-Inflammatory Mode of Action of Peptide 19-2.5 by Lena Heinbockel, Günther Weindl, Wilmar Correa, Julius Brandenburg, Norbert Reiling, Karl-Heinz Wiesmüller, Tobias Schürholz, Thomas Gutsmann, Guillermo Martinez de Tejada, Karl Mauss, Klaus Brandenburg

    Published 2021-02-01
    Get full text
    Article
  7. 7
    Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis

    Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis by Rima El-Dirany, Celia Fernández-Rubio, José Peña-Guerrero, Esther Moreno, Esther Larrea, Socorro Espuelas, Fadi Abdel-Sater, Klaus Brandenburg, Guillermo Martínez-de-Tejada, Paul Nguewa

    Published 2022-11-01
    Get full text
    Article
  8. 8
    Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis.

    Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis. by Lena Heinbockel, Sebastian Marwitz, Sergio Barcena Varela, Raquel Ferrer-Espada, Norbert Reiling, Torsten Goldmann, Thomas Gutsmann, Walter Mier, Tobias Schürholz, Daniel Drömann, Klaus Brandenburg, Guillermo Martinez de Tejada

    Published 2015-01-01
    Get full text
    Article

Search Tools: